Table 2 Clinical and biochemical parameters of cases and controls
From: Noninvasive tool for the diagnosis of NAFLD in association with atherosclerotic cardiovascular risk
Variable | Cases (n = 60) | Controls (n = 30) | p |
|---|---|---|---|
Age (years) | 42.1 ± 6.75 | 42.06 ± 8.1 | 0.989 |
SBP (mmHg) | 130.17 ± 10.3 | 121.67 ± 12.2 | 0.029 |
DBP (mmHg) | 80.70 ± 8.6 | 76.33 ± 7.7 | 0.09 |
ALT (U/L) | 39.2 ± 9.3 | 13.5 ± 3.6 | < 0.01 |
AST (U/L) | 34.1 ± 6.73 | 16.07 ± 3.51 | < 0.01 |
ALP (U/L) | 138.4 ± 31.7 | 134.3 ± 18.0 | 0.59 |
T. Bil (mg/dl) | 0.675 ± 0.4 | 0.5 ± 0.4 | 0.1 |
D. Bil (mg/dl) | 0.3 ± 0.2 | 0.3 ± 0.35 | 0.8 |
Albumin (mg/dl) | 4.05 ± 0.39 | 4.43 ± 0.45 | 0.01 |
PT (seconds) | 12.69 ± 0.82 | 12.58 ± 0.42 | 0.55 |
INR | 1.06 ± 0.12 | 0.99 ± 0.08 | 0.03 |
FBS (mg/dl) | 97.77 ± 14.17 | 79.53 ± 8.28 | 0.945 |
HbA1c | 5.35 ± 1.16 | 5.09 ± 0.43 | 0.282 |
Fasting insulin (μU/ml) | 8.75 ± 5.05 | 8.6 ± 1.9 | 0.866 |
HOMA-IR | 1.95 ± 1.8 | 2 ± 0.67 | 0.539 |
Triglycerides (mg/dl) | 124.37 ± 29.4 | 92.8 ± 21.58 | < 0.01 |
Cholesterol (mg/dl) | 173.3 ± 40.3 | 141.3 ± 15.5 | < 0.01 |
HDL (mg/dl) | 46.2 ± 7.9 | 54.7 ± 7.3 | 0.001 |
LDL (mg/dl) | 99.5 ± 32.5 | 87 ± 17 | < 0.01 |